TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: safety of levocetirizine
Endpoint domain: Adverse events/effects
Primary endpoint: Change in arterial endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain grade of 1 or less
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epidermal toxic response (ETR) of 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom severity scale of the Boston Carpal Tunnel Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional severity scale of the Boston Carpal Tunnel Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change in fitness level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in Pulmonary Vascular Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Metabolic activity at visceral sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic activity at metastatic sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Differences in metabolic activity at visceral and metastatic sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference in lung NTDmean
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in Pain Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Fear of Movement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in lean tissue mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in leg press strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in bench press strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in aerobic capacity as predicted by the Leger shuttle run test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in leg power as assessed by vertical jump height
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Correlation and agreement between AutoPEEP measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence of combined adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: ADP/ATP measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Doctor and Hospital Costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean total depression score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the PTSD Checklist (PCL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delivery Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Clinically Significant Improvement in Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Composite of nonfatal stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sciatica pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breathing pattern diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Breathing pattern variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Antibiotic free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of subjects with any SAE related to the study vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of subjects with any unsolicited or solicited Grade 3 or higher adverse event related to the study vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of subjects with solicited local AEs after each vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Achieving ASAS40 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of Global Perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in PROMIS Anxiety Short Form scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in PROMIS Depression Short Form scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tilting angle between Inferior Vena Cava and Günther Tulip Filter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child linear growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child hemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pregnancy weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy weight retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in thickness of retinal nerve fiber layer (RNFL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Accuracy of Smartphone Pulse Oximeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient trust in healthcare
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Histological Ki67 cancer cell proliferation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Anorectal manometry results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Parent Global Impressions of Autism
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for Toothwave device usage
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Low density lipoprotein (LDL) goal achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hemoglobin A1c (HbA1c) goal achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood pressure (BP) goal achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NETs rate at diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Total Dialysate Clearance for Automated Peritoneal Dialysis (CLDAPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: AUC120, AUC168 and AUCinf of Oseltamivir and Oseltamivir Carboxylate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax of Oseltamivir and Oseltamivir Carboxylate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in labelled (15N-nitrogen) and total nitrogen excretion in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in labelled (15N-urea) and total urea excretion in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in labelled (15N-ammonia) and total ammonia excretion in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in plasma TGF-Beta 1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cancers detected at stage I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in osteoprotegerin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in endocan level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in monthly migraine period rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in adherence to NIV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VLDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of perforators found intraoperatively not seen preoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy of preoperative CT angiography in predicting perforator vessels used
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Medication Adherence-Percentage of Pills Taken
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bone defect connection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects With Treatment-emergent Adverse Events Associated With the Oral Cavity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects With Mild, Moderate or Severe Treatment-emergent Adverse Events Associated With the Oral Cavity
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under Curve (AUC) for Primaquine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Curve (AUC) for Dihydroartemisinin (DHA) and Piperaquine (PQP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day composite of stroke or death
Endpoint domain: Mortality/survival
Primary endpoint: percentage of subjects with new ischemic injury on diffusion MRI imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: amount of infarcted tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in mean total UPDRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax (Candesartan cilexetil)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax (Atorvastatin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast (Candesartan cilexetil)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast (Atorvastatin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hourly ropivacaine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain Structure Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: First pain medication request
Endpoint domain: Adverse events/effects
Primary endpoint: Change in knee extension strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of patients with persisting infections
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with newly developed infections
Endpoint domain: Adverse events/effects
Primary endpoint: Deans Alopecia Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Single-operator intubation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Plasma viral RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Relative Mean Difference in Contrast Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical side infection
Endpoint domain: Adverse events/effects
Primary endpoint: Pain measured at mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects remaining malaria-free
Endpoint domain: Mortality/survival
Primary endpoint: Genetic variation associated with Hirschsprung disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevention of COVID-19 symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as determined by presence or absence of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Portosystemic pressure gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Azygos flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Calories consumed during buffet meal test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Compliance With Study Fluid Administration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in ADAMTS13-Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infection with virus strain type A or type B
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With at Least 1 Treatment Emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Serum Sex Hormone Binding Globulin (SHBG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: change in the density of capillaries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Optimal laryngeal mask airway cuff volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood flow patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of virus DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Overall disease activity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With a Closed Patent Ductus Arteriosus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Completion of health risk assessment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Evolution of the relative area of the white spot lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of the Andersson Index of the white spot lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of HBI-8000
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Appropriate Decline in Serum Rapid Plasma Reagin Test (RPR) Titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Improvement in Performance on CogState Battery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of subjects reporting vaginal symptoms occurring 'often' and 'frequently'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects reporting 'moderate' and 'severe' vaginal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PYY secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Anti-retroviral therapy non-adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 5-year Relapse-free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: CYP2B6 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CYP2D6 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CYP2C9 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year conversion rate of psychosis
Endpoint domain: Mortality/survival
Primary endpoint: Lipoic Acid Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cAMP Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Development of left ventricular remodelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Morphed Face Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional Memory Tradeoff Memory Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: exosomal PD1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: exosomal PD-L1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HCV RNA level on Day 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response at Week 24 according to a combined response index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response and Progression Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ICU care risk factors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ICU mortality risk factors
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of acute clinical renal graft rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Opinion of the Products' Flavor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Opinion of the Amount of Flavor in the Products
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Opinion of the Products' Sweetness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Execution time - Stroop task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Errors - Stroop task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Execution time - Go No Go task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variability of execution time - Go No Go task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Errors - Go No Go task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious forms identified by clinical site or hospitalisation unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of contralateral neck of femur fracture
Endpoint domain: Mortality/survival
Primary endpoint: Montgomery-Asberg Depression Rating Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Partial Pressure of CO2 in Arterial or Venous Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SpO2 Levels During Various Modes of Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of Change in Composite Manual Muscle Testing (MMT) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incremental plasma short-chain fatty acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Length of hospital stay (number of days)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Overall pre-procedure anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety of CAR-T cells
Endpoint domain: Adverse events/effects
Primary endpoint: 24-h urinary sodium excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Evaluation of the immune related or radiation therapy related toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of the primary surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Demonstration of the tumour response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sleep architecture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary Outcome Measure
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: RNA suitability for gene expression tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay between T0 and Time of occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of fracture healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Skin inflammatory response measurement as induration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin inflammatory response measurement as erythema diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Characterisation of T-cells in a skin DTH response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of late IOL complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean relative change in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in nutritional status on the Mini Nutritional Assessment (MNA) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in s-albumin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Children Who Don't Feel Pain or Have Mild Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes